Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation

Explore clinical trials studying Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation trial results

Completed

AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

NCT04380753

Conditions: Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation
Locations: University of Hong Kong, Queen Mary Hospital Hong Kong

Prince of Wales Hospital Shatin, New Territories, Hong Kong

Veterans General Hospital - Taichung Taichung, Taiwan

National Taiwan University Hospital Taipei, Taiwan

View Trial Details